Cargando…

Expression Profiles and Prognostic Value of Multiple Inhibitory Checkpoints in Head and Neck Lymphoepithelioma-Like Carcinoma

BACKGROUND: Inhibitory checkpoints are promising antitumor targets and predictive biomarkers in a variety of cancers. We aimed to identify the expression levels and prognostic value of multiple inhibitory checkpoints supported by preclinical and clinical evidence in head and neck lymphoepithelioma-l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Wen-Qing, Luo, Wei-Jie, Feng, Yan-Fen, Liu, Fang, Liang, Shao-Bo, Fang, Xue-Liang, Liang, Ye-Lin, Liu, Na, Wang, Ya-Qin, Mao, Yan-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818848/ https://www.ncbi.nlm.nih.gov/pubmed/35140722 http://dx.doi.org/10.3389/fimmu.2022.818411

Ejemplares similares

Prognostic Value of an Immunohistochemical Signature in Patients With Head and Neck Mucosal Melanoma
por: Xu, Qing-Qing, et al.
Publicado: (2021)

Prognostic Value of Neoantigen Load in Immune Checkpoint Inhibitor Therapy for Cancer
por: Zou, Xue-lin, et al.
Publicado: (2021)

Head and neck cancer. An aetiopathogenetic study of non-endemic lymphoepithelioma
por: CASCO, F.G., et al.
Publicado: (2013)

Immune Checkpoint Inhibition in Head and Neck Cancer
por: Forster, Martin David, et al.
Publicado: (2018)

Risk of head and neck cancer in relation to blood inflammatory biomarkers in the Swedish AMORIS cohort
por: Yang, Yanping, et al.
Publicado: (2023)

Prognostic value of the immunohistochemical score based on four markers in head and neck squamous cell carcinoma
por: Xu, Qing-Qing, et al.
Publicado: (2023)

The Common Costimulatory and Coinhibitory Signaling Molecules in Head and Neck Squamous Cell Carcinoma
por: Liao, Peng, et al.
Publicado: (2019)

PD-1/PD-L1 combined with LAG3 is associated with clinical activity of immune checkpoint inhibitors in metastatic primary pulmonary lymphoepithelioma-like carcinoma
por: Zhong, Yu-Min, et al.
Publicado: (2022)

Inhibitory Immune Checkpoint Receptors and Ligands as Prognostic Biomarkers in COVID-19 Patients
por: Al-Mterin, Mohammad A., et al.
Publicado: (2022)

On the Road to Immunotherapy—Prospects for Treating Head and Neck Cancers With Checkpoint Inhibitor Antibodies
por: Ward, Frank J., et al.
Publicado: (2018)

Prognostic value of immune checkpoint molecules in head and neck cancer: a meta-analysis
por: Jia, Yi-Qun, et al.
Publicado: (2019)

Anti-PD-1 antibodies, a novel treatment option for advanced chemoresistant pulmonary lymphoepithelioma carcinoma
por: Zhou, Na, et al.
Publicado: (2022)

The Double-Edged Sword—How Human Papillomaviruses Interact With Immunity in Head and Neck Cancer
por: Wang, Hao-fan, et al.
Publicado: (2019)

The Evolving Landscape of PD-1/PD-L1 Pathway in Head and Neck Cancer
por: Qiao, Xin-wei, et al.
Publicado: (2020)

Non-coding RNA-mediated high expression of SFXN3 as a prognostic biomarker associated with paclitaxel resistance and immunosuppressive microenvironment in head and neck cancer
por: Chen, Kailin, et al.
Publicado: (2022)

Prognostic value of PD-1, PD-L1 and PD-L2 deserves attention in head and neck cancer
por: Jiang, Siqing, et al.
Publicado: (2022)

Diagnostic and prognostic value of circRNAs expression in head and neck squamous cell carcinoma: A meta‐analysis
por: Feng, Huajun, et al.
Publicado: (2022)

Checkpoint Inhibition in the Treatment of Unresectable, Advanced Lymphoepithelioma-like Hepatocellular Carcinoma
por: Hermel, David J., et al.
Publicado: (2021)

The prognostic impact of the immune signature in head and neck squamous cell carcinoma
por: Baysal, Hasan, et al.
Publicado: (2022)

Prognostic Value of HIFs Expression in Head and Neck Cancer: A Systematic Review
por: Gong, Liang, et al.
Publicado: (2013)

A Metabolism-Related Gene Prognostic Index Bridging Metabolic Signatures and Antitumor Immune Cycling in Head and Neck Squamous Cell Carcinoma
por: Du, Kunpeng, et al.
Publicado: (2022)

Multi-Omics Data Analyses Identify B7-H3 as a Novel Prognostic Biomarker and Predict Response to Immune Checkpoint Blockade in Head and Neck Squamous Cell Carcinoma
por: Lin, Wanzun, et al.
Publicado: (2021)

Predictive Value of KDM5C Alterations for Immune Checkpoint Inhibitors Treatment Outcomes in Patients With Cancer
por: Chen, Xiao-Juan, et al.
Publicado: (2021)

Pulmonary Lymphoepithelioma-Like Carcinoma: A Mini-Review
por: Hu, Yan, et al.
Publicado: (2020)

DNA Vaccines Targeting Novel Cancer-Associated Antigens Frequently Expressed in Head and Neck Cancer Enhance the Efficacy of Checkpoint Inhibitor
por: Wang, Chuan, et al.
Publicado: (2021)

Immune checkpoint blockade induced shifts in cytokine expression patterns in peripheral blood of head and neck cancer patients are linked to outcome
por: Röhl, Louisa, et al.
Publicado: (2023)

Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma
por: Wang, Sha-sha, et al.
Publicado: (2016)

Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer
por: Sivori, Simona, et al.
Publicado: (2020)

Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression
por: Saleh, Reem, et al.
Publicado: (2020)

Editorial: Genomics, proteomics and immunological signatures as diagnostic, predictive, and prognostic biomarkers in head and neck cancers
por: Raza, Afsheen, et al.
Publicado: (2023)

Regulation of epigenetic modifications in the head and neck tumour microenvironment
por: Liu, Huimin, et al.
Publicado: (2022)

Interleukin-33: Metabolic checkpoints, metabolic processes, and epigenetic regulation in immune cells
por: Lin, Jian, et al.
Publicado: (2022)

An ion-channel-gene-based prediction model for head and neck squamous cell carcinoma: Prognostic assessment and treatment guidance
por: Han, Yanxun, et al.
Publicado: (2022)

Prognostic value of immune checkpoint molecules in breast cancer
por: Fang, Jun, et al.
Publicado: (2020)

The role of cuproptosis-related gene in the classification and prognosis of melanoma
por: Liu, Jin-Ya, et al.
Publicado: (2022)

PD-1 inhibition plus platinum-based chemotherapy (PBC) or PBC alone in the first-line treatment of locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma
por: Zhang, Xuanye, et al.
Publicado: (2022)

Combined bulk RNA-seq and single-cell RNA-seq identifies a necroptosis-related prognostic signature associated with inhibitory immune microenvironment in glioma
por: Wan, Sicheng, et al.
Publicado: (2022)

DCBLD1 Overexpression Is Associated With a Poor Prognosis in Head and Neck Squamous Cell Carcinoma
por: Fu, Ling-ling, et al.
Publicado: (2022)

Lymphoepithelioma-like hepatocellular carcinoma: A case report and brief review of literature
por: Wang, Jun-Ke, et al.
Publicado: (2017)

Predictive value of PIMREG in the prognosis and response to immune checkpoint blockade of glioma patients
por: Zhu, Hua, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_97fq79rnbc6uhe0icehqo6g1eq